Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia

Published:2018-03-06 Issue:8 Volume:50 Page:643-647
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Cortes-Penfield Nicolas¹,Oliver Nora T.²³,Hunter Andrew⁴,Rodriguez-Barradas Maria¹⁴

Affiliation:

1. Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA;

2. Section of Infectious Diseases, Atlanta VA Medical Center, Atlanta, GA, USA;

3. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA;

4. Section of Infectious Diseases, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2018.1448110

Reference9 articles.

1. A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)

2. Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model

3. Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial

4. Predictors and clinical outcomes of persistent methicillin-resistantStaphylococcus aureusbacteremia: a prospective observational study

5. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in anIn VitroPharmacokinetic/Pharmacodynamic Model

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on the screening methods for the discovery of natural antimicrobial peptides;Journal of Pharmaceutical Analysis;2024-07

2. Getting to the heart of the matter—are two agents really better than one for the treatment of staphylococcal infective endocarditis?;International Journal of Infectious Diseases;2024-05

3. Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis;Heliyon;2024-04

4. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future;Expert Opinion on Drug Safety;2023-12-25

5. New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended;Journal of Clinical Medicine;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3